Publicaciones en colaboración con investigadoras/es de Hospital Vall d'Hebron (19)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

2023

  1. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  2. Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

2022

  1. Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children

    European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115

  2. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  3. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

    Pediatric Blood and Cancer, Vol. 69, Núm. 11

  4. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

    Anales de Pediatria, Vol. 97, Núm. 2, pp. 130.e1-130.e7

2020

  1. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

  2. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

    Journal of Clinical Immunology, Vol. 40, Núm. 6, pp. 901-916

2019

  1. Burkitt-like lymphoma with 11q aberration: A germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma

    Haematologica, Vol. 104, Núm. 9, pp. 1822-1829

  2. ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1763-1770

2017

  1. Early clinical trials in paediatric oncology in Spain: a nationwide perspective

    Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163

2016

  1. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

  2. Landscape of early clinical trials for childhood and adolescence cancer in Spain

    Clinical and Translational Oncology, Vol. 18, Núm. 7, pp. 708-713

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Actualización del tratamiento con L-asparraginasa en Pediatría

    Anales de Pediatria, Vol. 79, Núm. 5

  2. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745